Aldara and Dyspnea exacerbated - a phase IV clinical study of FDA data

Summary:

Dyspnea exacerbated is reported as a side effect among people who take Aldara (imiquimod), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Dyspnea exacerbated when taking Aldara. It is created by eHealthMe based on reports of 2,478 people who have side effects when taking Aldara from the FDA, and is updated regularly.

What is Aldara?

Aldara has active ingredients of imiquimod. It is often used in genital warts. eHealthMe is studying from 2,554 Aldara users. Check the latest studies of Aldara.

What is Dyspnea exacerbated?

Dyspnea exacerbated is found to be associated with 3,301 drugs and 1,658 conditions by eHealthMe. Check the latest studies of Dyspnea exacerbated.

On Jul, 22, 2026

2,478 people reported to have side effects when taking Aldara.
Among them, 45 people (1.82%) have Dyspnea exacerbated.

Among these 45 people:

How long have people been on Aldara when they have Dyspnea exacerbated? *

What is the gender of people who have Dyspnea exacerbated when taking Aldara? *

female: 60 %
male: 40 %

What is the age of people who have Dyspnea exacerbated when taking Aldara? *

What are other drugs people take besides Aldara? *

What are other side effects people have besides Dyspnea exacerbated? *

Fatigue (feeling of tiredness): 16 people, 35.56%
Chest Pain: 16 people, 35.56%
Rashes (redness): 14 people, 31.11%
Pain: 13 people, 28.89%
Influenza Like Illness: 12 people, 26.67%
Dizziness: 11 people, 24.44%
Fall: 9 people, 20.00%
Hyperhidrosis (abnormally increased sweating): 8 people, 17.78%
Pain In Extremity: 8 people, 17.78%
Headache (pain in head): 8 people, 17.78%

What are the existing conditions these people have? *

Depression: 3 people, 6.67%
Skin Cancer: 3 people, 6.67%
Skin Papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections): 3 people, 6.67%
Multiple Myeloma (cancer of the plasma cells): 3 people, 6.67%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 2 people, 4.44%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.44%
Breast Cancer: 2 people, 4.44%
Menopausal Symptoms: 2 people, 4.44%
Pleurisy (inflammation of the pleurae, which causes pain when breathing): 2 people, 4.44%
Polyarthritis (arthritis which involves 5 or more joints simultaneously): 2 people, 4.44%

* Approximation only. Some reports may have incomplete information.

Do you take Aldara and have Dyspnea exacerbated?

- Check whether Dyspnea exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aldara:

Aldara (2,554 reports)

Browse all side effects of Aldara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (3,301 drugs)

Browse all the conditions that are associated with Dyspnea exacerbated:

Dyspnea exacerbated (1,658 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on imiquimod (the active ingredients of Aldara) and Aldara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.